Aspirin Resistance and Cardiovascular Outcomes
Paul S. Mueller, FACP. FACP.
Abstract
Paul S. Mueller, FACP. FACP.
Abstract
Despite taking aspirin daily, many patients with established cardiovascular disease experience myocardial infarction, stroke, or cardiovascular death. “Aspirin resistance” — persistent platelet reactivity despite aspirin therapy — could account for some of these events. Few researchers, however, have assessed how aspirin resistance affects outcomes in patients with cardiovascular …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Despite taking aspirin daily, many patients with established cardiovascular disease experience myocardial infarction, stroke, or cardiovascular death. “Aspirin resistance” — persistent platelet reactivity despite aspirin therapy — could account for some of these events. Few researchers, however, have assessed how aspirin resistance affects outcomes in patients with cardiovascular …
Key concepts: Aspirin, Medicine, Myocardial infarction, Stroke (engine), Cardiology, Internal medicine, Disease, Intensive care medicine